ClinConnect ClinConnect Logo
Search / Trial NCT05891015

The Mechanism of Mindfulness Intervention to Alleviate Emotional Distress in Patients With Emotional Disorders

Launched by PEKING UNIVERSITY · May 26, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how mindfulness practices, both in-person and online, can help reduce emotional distress in people with emotional disorders. Researchers want to see if these mindfulness techniques can make a difference in how individuals handle their emotions and improve their overall emotional well-being. They will also look at how certain factors, like the ability to adapt thinking and cope with stress, play a role in the effectiveness of mindfulness.

To take part in this study, participants should be between the ages of 65 and 74 and have a score of more than 21 on a specific distress scale, indicating significant emotional distress. They must have been diagnosed with an emotional disorder in the last six months. However, some individuals, such as those with certain mental health conditions or those who have recently practiced mindfulness extensively, will not be eligible. The trial is not yet accepting participants, but once it starts, those involved can expect to engage in mindfulness activities and share their experiences to help researchers better understand its benefits.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects with scores greater than 21 on the Kessler Psychological Distress Scale.
  • Subjects have been diagnosed emotional disorders in the past 6 months.
  • Exclusion Criteria:
  • Subjects who could not access the Internet;
  • Subjects with insufficient Chinese ability;
  • Subjects who have participated in mindfulness based projects for more than 6 weeks before, and / or the current frequency of meditation practice is more than once a week;
  • Patients with schizophrenia or psychotic affective disorder, current organic mental disorder, substance abuse disorder and generalized developmental disorder;
  • Subjects at risk of suicide.

About Peking University

Peking University is a prestigious institution located in Beijing, China, recognized for its commitment to advancing medical research and education. As a clinical trial sponsor, Peking University leverages its extensive academic resources and collaborative networks to drive innovative healthcare solutions. The university's focus on rigorous scientific methodologies and adherence to ethical standards ensures the integrity and reliability of its clinical research initiatives. By fostering interdisciplinary partnerships, Peking University aims to translate groundbreaking discoveries into tangible health benefits, contributing to the global advancement of medical science.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Xinghua Liu

Principal Investigator

School of Psychological and Cognitive Sciences, Peking University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported